Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Linagliptin reduces effects of ET-1 and TLR2-mediated cerebrovascular hyperreactivity in diabetes.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Linagliptin reduces effects of ET-1 and TLR2-mediated cerebrovascular hyperreactivity in diabetes.
Linagliptin reduces effects of ET-1 and TLR2-mediated cerebrovascular hyperreactivity in diabetes. Life Sci. 2016 Aug 15; 159:90-96.
View in:
PubMed
subject areas
Animals
Blood Glucose
Cells, Cultured
Cerebrovascular Circulation
Diabetes Mellitus, Experimental
Endothelin-1
Hypoglycemic Agents
Linagliptin
Male
Rats
Rats, Wistar
Toll-Like Receptor 2
authors with profiles
Yasir Abdul
Adviye Ergul